Effective execution is now the key
Nanosonics specialises in the low-temperature disinfection of instruments and devices based on its patented NanoNebulant technology. Its first product, the Trophon EPR, is used to disinfect ultrasound probes and is launched in the US (marketed by GE Healthcare), Europe and Australia. The sizeable market potential suggests material revenue and earnings growth.
Novel technology for rapid and effective disinfection
Nanosonics was founded in 2001 and is based in Sydney. It is a leader in infection control technology solutions, having developed easy-to-use, environmentally friendly and quality assured products since 2009. The lead product, Trophon EPR, uses the proprietary NanoNebulant technology to generate a super-fine hydrogen peroxide mist to disinfect ultrasound probes. It received US FDA approval in 2011 and is partnered with GE Healthcare, the leading ultrasound manufacturer, and sold through a dedicated sales force that is gaining good traction in this important market.
More effective, more convenient, faster and safer
Conventional manual and liquid-based ultrasound probe disinfection practices have changed little in the past 20 years and are associated with multiple issues (including the level of sterilisation, the time required and potential exposure to hazardous chemicals on the part of hospital workers). By contrast, Trophon EPR is rapid (just seven minutes, so potentially saving seven and a half hours a week), highly effective and safe since it produces only water and oxygen as by-products.
To Read the Entire Report Please Click on the pdf File Below